John C. Martin

1.9k total citations
38 papers, 1.5k citations indexed

About

John C. Martin is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, John C. Martin has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 18 papers in Organic Chemistry and 15 papers in Molecular Biology. Recurrent topics in John C. Martin's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (11 papers) and Biochemical and Molecular Research (9 papers). John C. Martin is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (11 papers) and Biochemical and Molecular Research (9 papers). John C. Martin collaborates with scholars based in United States, Belgium and Australia. John C. Martin's co-authors include Michael J. M. Hitchcock, Thomas R. Matthews, Muzammil M. Mansuri, D. F. SMEE, Joanne J. Bronson, John E. Starrett, David R. Tortolani, Howard S. Jaffe, Robert Stagg and Hilde De Boeck and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

John C. Martin

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by John C. Martin

Since Specialization

Citations

This map shows the geographic impact of John C. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Martin more than expected).

Fields of papers citing papers by John C. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Martin. The network helps show where John C. Martin may publish in the future.

Co-authorship network of co-authors of John C. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Martin. A scholar is included among the top collaborators of John C. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Martin. John C. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosides 2009 ·Antiviral Research ·John C. Martin, Michael J. M. Hitchcock, Erik De Clercq, William H. Prusoff	43
2	Cidofovir, a New Agent with Potent Anti-Herpesvirus Activity 1996 ·Antiviral chemistry & chemotherapy ·Michael J. M. Hitchcock, Howard S. Jaffe, John C. Martin, Robert Stagg	110
3	Prodrugs of 2’,3’-Didehydro-3’-deoxythymidine (D4T): Synthesis, Antiviral Activity, and Rapid Pharmacokinetic Evaluation 1994 ·Journal of Pharmaceutical Sciences ·David R. Tortolani, John W. Russell, Valerie Whiterock, Muzammil M. Mansuri, John E. Starrett, Michael J. M. Hitchcock, John C. Martin	5
4	Synthesis and antiviral activity of 2'-substituted 9-[2-(phosphonomethoxy)ethyl]guanine analogs 1993 ·Journal of Medicinal Chemistry ·(unknown), Joanne J. Bronson, Hua Yang, Amy K. Patick, Masud Alam, V Brankovan, R. Datema, Michael J. M. Hitchcock, John C. Martin	20
5	Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine 1992 ·Antiviral Research ·John E. Starrett, David R. Tortolani, Michael J. M. Hitchcock, John C. Martin, Muzammil M. Mansuri	92
6	Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. 1992 ·Molecular Pharmacology ·(unknown), (unknown), Joanne J. Bronson, Hilde De Boeck, John C. Martin, Michael J. M. Hitchcock	153
7	Synthesis and biological activity of carbocyclic derivatives of the potent antiviral agent 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG) 1992 ·Bioorganic & Medicinal Chemistry Letters ·Joanne J. Bronson, (unknown), John C. Martin, Muzammil M. Mansuri	7
8	Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys 1991 ·Antiviral Research ·Kenneth F. Soike, (unknown), (unknown), (unknown), Michael J. M. Hitchcock, John C. Martin	51
9	Structural studies of the anti-HIV agent 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) 1991 ·Biochemical and Biophysical Research Communications ·William E. Harte, John E. Starrett, John C. Martin, Muzammil M. Mansuri	35
10	In Vivo Antitumor Activity of 9-[(2-Phosphonylmethoxy)ethyl]-guanine and Related Phosphonate Nucleotide Analogues 1990 ·JNCI Journal of the National Cancer Institute ·William C. Rose, Alfred R. Crosswell, Joanne J. Bronson, John C. Martin	49
11	Comparative Studies of 2′,3′‐Didehydro‐2′,3′‐Dideoxythymidine (D4T) with other Pyrimidine Nucleoside Analogues 1990 ·Annals of the New York Academy of Sciences ·John C. Martin, Michael J. M. Hitchcock, Arnold Fridland, Ismail Ghazzouli, Sanjeev Kaul, Lisa M. Dunkle, Roman Sterzycki, Muzammil M. Mansuri	17
12	(S)-1-(3-Hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): A Potent Antiherpesvirus Agent 1990 ·Advances in experimental medicine and biology ·Joanne J. Bronson, (unknown), Michael J. M. Hitchcock, (unknown), (unknown), Ismail Ghazzouli, Earl R. Kern, Kenneth F. Soike, John C. Martin	21
13	Synthesis of a Phosphonate Isostere of Acycylovir Monophosphate: A Herpesvirus Active Phosphonate Nucleotide Analogue 1990 ·Heterocycles ·Choung Un Kim, P. F. MISCO, (unknown), John C. Martin	4
14	Synthesis of a phosphonate isostere of ganciclovir monophosphate: A highly cytomegalovirus active phosphonate nucleotide analogue 1990 ·Tetrahedron Letters ·Choung Un Kim, P. F. MISCO, (unknown), John C. Martin	5
15	Synthesis and antiviral evaluation of 6'-substituted aristeromycins: potential mechanism-based inhibitors of S-adenosylhomocysteine hydrolase 1988 ·Journal of Medicinal Chemistry ·(unknown), D. P. C. MCGEE, Robert M. Rydzewski, Richard Boehme, John C. Martin, Ernest J. Prisbe	50
16	Late effects of fractionated pi-mesons compared to X rays on mouse lung 1988 ·International Journal of Radiation OncologyBiologyPhysics ·Albert J. van der Kogel, John C. Martin, Alfred R. Smith, (unknown)	8
17	Synthesis and anti-herpes virus activity of acyclic 2'-deoxyguanosine analogs related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine 1986 ·Journal of Medicinal Chemistry ·John C. Martin, D. P. C. MCGEE, (unknown), Doug W. Hobbs, Donald F. Smee, Thomas R. Matthews, (unknown)	46
18	A novel and stereospecific synthesis of (.+-.)- and (-)-aristeromycin 1986 ·The Journal of Organic Chemistry ·(unknown), John C. Martin	66
19	Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine 1983 ·Antimicrobial Agents and Chemotherapy ·D. F. SMEE, John C. Martin, (unknown), Thomas R. Matthews	222
20	Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry. 1982 ·PubMed ·(unknown), John C. Martin, Kohzoh Imai, Soldano Ferrone, Noel L. Warner	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact